What is Palmitoylethanolamide (PEA)?
Palmitoylethanolamide (PEA) is a naturally occurring lipid compound that is produced by the human body and present in various tissues. Chemically, it belongs to the family of fatty-acid ethanolamides, a group of bioactive lipids involved in normal biological processes.
Unlike vitamins or minerals, PEA is not classified as an essential nutrient. Instead, it is best described as an endogenous lipid mediator — a substance that the body synthesizes locally as part of its internal regulatory environment. Because of this endogenous nature, PEA is considered to have a high degree of physiological compatibility.
PEA has been known to science since the mid-20th century and has been extensively described in biochemical and molecular research literature. Over time, interest in PEA has increased as scientific understanding of lipid signaling, cellular communication, and regulatory balance has expanded.
Endogenous Nature and Biological Context
One of the defining characteristics of PEA is that it is produced on demand by cells, rather than stored in large quantities. This means its presence in tissues can vary depending on local biological conditions.
PEA is found in a wide range of human tissues and is also present in small amounts in certain foods. However, dietary intake alone is typically limited, which is why PEA has attracted attention as a distinct compound within advanced nutritional formulations.
From a biological perspective, PEA is often discussed in the context of:
- lipid signaling systems
- cellular communication networks
- interactions between metabolic and regulatory pathways
Importantly, PEA does not function as a stimulant, hormone, or neurotransmitter, nor does it act as a classical cannabinoid. Instead, it participates in subtle, modulatory processes that are part of normal physiology.
Relationship to Lipid Signaling and Regulatory Systems
PEA is frequently mentioned alongside research into lipid-based signaling mechanisms, including those related to fatty-acid metabolism and nuclear receptors involved in gene regulation.
Scientific literature often explores how PEA interacts with broader regulatory frameworks in the body, rather than targeting a single isolated pathway. This systems-level perspective distinguishes PEA from many compounds that are designed to act in a more direct or forceful manner.
Because PEA is structurally related to other endogenous lipid mediators, it is considered part of a wider family of naturally occurring regulatory molecules that help maintain internal balance.
Note: The information provided on this page is intended for general educational purposes only. No disease-related health claims have been authorized by regulatory authorities for palmitoylethanolamide (PEA).
Why Formulation Matters: PEA Pro Liposomal
PEA is a highly lipophilic (fat-soluble) molecule, which presents formulation challenges when used in food supplements. In conventional powder form, dispersion characteristics may vary depending on the digestive environment.
To address this, PEA Pro Liposomal is produced using a phospholipid-based pro-liposomal delivery system (LongLifeLipoTech®). This system incorporates sunflower lecithin–derived phospholipids together with vegan chitosan. Such approaches have been explored in formulation science for their ability to promote the formation of liposomal structures and to support improved dispersion of lipophilic compounds in aqueous environments.
Phospholipid-based delivery systems are commonly referred to as liposomal or pro-liposomal formulations. They are designed to mimic naturally occurring lipid structures found in biological membranes, allowing lipophilic compounds to be incorporated within a phospholipid matrix.
Conventional liposomal systems may carry an electrical surface charge, which can influence physical stability and interactions in biological environments. Strategies aimed at modulating surface charge have therefore been investigated to improve dispersion characteristics and formulation stability. One such approach includes the use of chitosan, a polysaccharide known to interact with phospholipid head groups in model systems.
LongLifeLipoTech® incorporates this advanced formulation concept by combining phospholipids with chitosan in a pro-liposomal matrix. The resulting system is designed to support the formation of neutrally charged liposomal structures, with the goal of enhancing formulation stability and biocompatibility compared to traditional phospholipid-only systems.
By leveraging this delivery platform, PEA Pro Liposomal reflects a formulation-focused approach that prioritizes dispersion, stability, and physiological alignment, without altering the chemical identity of palmitoylethanolamide itself.
Selected scientific references on TUDCA (References are provided for scientific transparency and do not constitute claims or recommendations regarding the use of this product.):
Petrosino S. et al. (2017) PubMed ID: 27539936, Gabrielsson L. et al. (2016) PubMed ID: 27220803, Hesselink J.M.K. (2013) PubMed ID: 24066256, Borrelli F. et al. (2015) PubMed ID: 25205418, Hesselink J.M.K. et al. (2012) PubMed ID: 23166447
Reviews
There are no reviews yet.